BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7474361)

  • 21. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
    Sanbe A; Tanonaka K; Niwano Y; Takeo S
    J Pharmacol Exp Ther; 1994 Apr; 269(1):51-6. PubMed ID: 8169851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
    Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
    Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.
    Fraccarollo D; Bauersachs J; Kellner M; Galuppo P; Ertl G
    Cardiovasc Res; 2002 Apr; 54(1):85-94. PubMed ID: 12062365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
    van Veldhuisen DJ; van Gilst WH; de Smet BJ; de Graeff PA; Scholtens E; Buikema H; Girbes AR; Wesseling H; Lie KI
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):245-50. PubMed ID: 7918137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term treatment with trandolapril on Hsp72 and Hsp73 induction of the failing heart following myocardial infarction.
    Tanonaka K; Toga W; Yoshida H; Furuhama K; Takeo S
    Br J Pharmacol; 2001 Nov; 134(5):969-76. PubMed ID: 11682444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment.
    Kelly MP; Kahr O; Aalkjaer C; Cumin F; Samani NJ
    Clin Sci (Lond); 1997 May; 92(5):455-65. PubMed ID: 9176018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.
    Fraccarollo D; Galuppo P; Hildemann S; Christ M; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2003 Nov; 42(9):1666-73. PubMed ID: 14607457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
    Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of growth hormone following chronic angiotensin-converting enzyme inhibition in chronic heart failure: their relation to infarct size.
    Hongo M; Hironaka E; Yokoseki O; Watanabe N; Shibamoto T; Owa M; Ryoke T
    Cardiovasc Drugs Ther; 2001; 15(3):241-9. PubMed ID: 11713892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
    Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
    Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
    Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
    Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology.
    Pinto YM; de Smet BG; van Gilst WH; Scholtens E; Monnink S; de Graeff PA; Wesseling H
    Cardiovasc Res; 1993 Nov; 27(11):1933-8. PubMed ID: 8287399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors.
    Takai S; Jin D; Sakaguchi M; Miyazaki M
    Hypertens Res; 2004 Mar; 27(3):213-9. PubMed ID: 15080380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy.
    Ruzicka M; Leenen FH
    Circulation; 1995 Jan; 91(1):16-9. PubMed ID: 7805197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.
    Varin R; Mulder P; Tamion F; Richard V; Henry JP; Lallemand F; Lerebours G; Thuillez C
    Circulation; 2000 Jul; 102(3):351-6. PubMed ID: 10899101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
    Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trandolapril dose-response in spontaneously hypertensive rats: effects on ACE activity, blood pressure, and cardiac hypertrophy.
    Jouquey S; Stepniewski JP; Hamon G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S16-8. PubMed ID: 7527096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.